Εμφάνιση απλής εγγραφής

dc.creatorŠušnjar U., Škrabar N., Brown A.-L., Abbassi Y., Phatnani H., Phatnani H., Fratta P., Kwan J., Sareen D., Broach J.R., Simmons Z., Arcila-Londono X., Lee E.B., Van Deerlin V.M., Shneider N.A., Fraenkel E., Ostrow L.W., Baas F., Berry J.D., Butovsky O., Baloh R.H., Shalem O., Heiman-Patterson T., Stefanis L., Chandran S., Pal S., Smith C., Malaspina A., Hammell M.G., Patsopoulos N.A., Dubnau J., Poss M., Zhang B., Zaitlen N., Hornstein E., Miller T.M., Dardiotis E., Bowser R., Menon V., Harms M., Atassi N., Lange D.J., MacGowan D.J., McMillan C., Aronica E., Harris B., Ravits J., Crary J., Thompson L.M., Raj T., Paganoni S., Adams D.J., Babu S., Drory V., Gotkine M., Broce I., Phillips-Cremins J., Nath A., Finkbeiner S., Cox G.A., Cortese A., Cereda C., Bugiardini E., Cardani R., Meola G., Ripolone M., Moggio M., Romano M., Secrier M., Fratta P., Buratti E., NYGC ALS Consortiumen
dc.date.accessioned2023-01-31T10:04:46Z
dc.date.available2023-01-31T10:04:46Z
dc.date.issued2022
dc.identifier10.1038/s42003-022-03253-8
dc.identifier.issn23993642
dc.identifier.urihttp://hdl.handle.net/11615/79526
dc.description.abstractTDP-43 (TAR DNA-binding protein 43) aggregation and redistribution are recognised as a hallmark of amyotrophic lateral sclerosis and frontotemporal dementia. As TDP-43 inclusions have recently been described in the muscle of inclusion body myositis patients, this highlights the need to understand the role of TDP-43 beyond the central nervous system. Using RNA-seq, we directly compare TDP-43-mediated RNA processing in muscle (C2C12) and neuronal (NSC34) mouse cells. TDP-43 displays a cell-type-characteristic behaviour targeting unique transcripts in each cell-type, which is due to characteristic expression of RNA-binding proteins, that influence TDP-43’s performance and define cell-type specific splicing. Among splicing events commonly dysregulated in both cell lines, we identify some that are TDP-43-dependent also in human cells. Inclusion levels of these alternative exons are altered in tissues of patients suffering from FTLD and IBM. We therefore propose that TDP-43 dysfunction contributes to disease development either in a common or a tissue-specific manner. © 2022, The Author(s).en
dc.language.isoenen
dc.sourceCommunications Biologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85127682262&doi=10.1038%2fs42003-022-03253-8&partnerID=40&md5=ae845821bf7689a75d0e883326f80e04
dc.subjectDNA binding proteinen
dc.subjectTDP-43 protein, mouseen
dc.subjectamyotrophic lateral sclerosisen
dc.subjectanimalen
dc.subjectfrontotemporal dementiaen
dc.subjectgeneticsen
dc.subjecthumanen
dc.subjectmetabolismen
dc.subjectmouseen
dc.subjectmuscleen
dc.subjectRNA splicingen
dc.subjectAmyotrophic Lateral Sclerosisen
dc.subjectAnimalsen
dc.subjectDNA-Binding Proteinsen
dc.subjectFrontotemporal Dementiaen
dc.subjectHumansen
dc.subjectMiceen
dc.subjectMusclesen
dc.subjectRNA Splicingen
dc.subjectNature Researchen
dc.titleCell environment shapes TDP-43 function with implications in neuronal and muscle diseaseen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής